Company Filing History:
2 out of 1,745 
2 out of 29 
1 out of 157 
Years Active: 2019-2022
Title: Christian Recher: Innovator in Cancer Treatment
Introduction
Christian Recher is a notable inventor based in Toulouse, France. He has made significant contributions to the field of oncology, particularly in the treatment of chemoresistant acute myeloid leukemia (AML). With a total of 2 patents, his work focuses on innovative pharmaceutical compositions aimed at improving patient outcomes.
Latest Patents
One of his latest patents involves pharmaceutical compositions for the treatment of chemoresistant acute myeloid leukemia (AML). This invention relates to a powerful preclinical model that screens in vivo responses to conventional genotoxics, mimicking the chemoresistance and minimal residual disease observed in AML patients post-chemotherapy. The research highlights the cytarabine-resistance mechanism, which involves the CD39-dependent crosstalk between the energetic niche and AML mitochondrial functions through the CD39-P2Y13-cAMP-PKA signaling axis. The invention proposes an inhibitor of this signaling axis for treating patients with chemoresistant AML.
Another significant patent by Recher concerns Dendrogenin A and antineoplastic agents for the treatment of both chemosensitive and chemoresistant tumors. This invention includes a kit-of-parts comprising Dendrogenin A or its pharmaceutically acceptable salt, along with an antineoplastic agent for cancer treatment. The research emphasizes the potential of Dendrogenin A in treating chemoresistant cancers.
Career Highlights
Christian Recher has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the University Hospital of Toulouse (Centre Hospitalier Universitaire De Toulouse). His work in these organizations has contributed to advancements in medical research and treatment methodologies.
Collaborations
Throughout his career, Recher has collaborated with notable colleagues, including Jean-Emmanuel Sarry and Fabienne De Toni-Costes. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer treatment.
Conclusion
Christian Recher is a prominent figure in the field of cancer research, with a focus on developing innovative treatments for chemoresistant conditions. His contributions through patents and collaborations continue to impact the medical community positively.